Renalytix director Levangie resigns; shareholders authorize share allotment up to ~35% of enlarged capital

Renalytix plc

Dan Levangie resigned as Non-Executive Director effective Oct 31, 2024, citing no disagreement.
Shareholders passed all three resolutions with >98.7% votes in favor at Oct 31 general meeting.
Board authorized share allotment up to ~35% of enlarged share capital; specific nominal amounts for bonds/placements.
Julian Baines MBE appointed as director effective from close of GM with 99.85% votes in favor.

item 5.02 item 5.07 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Daniel Levangie

Non-Executive Director

RNLXY · Renalytix plc

Effective: 2024-10-31
Filed: November 6, 2024, 6:59 PM ET

Daniel Levangie, tendered his resignation from the Company's Board of Directors and all committees effective on October 31, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Daniel Levangie resigned as Non-Executive Director at Renalytix plc.

Action: resigned
Role: Non-Executive Director

Exact text from the filing

Daniel Levangie, tendered his resignation from the Company's Board of Directors and all committees effective on October 31, 2024.

View on SEC.gov

Renalytix plc filing history →

Source: SEC EDGAR

accession 0001213900-24-095002

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.